NCT03652493View on ClinicalTrials.gov

Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

April 27, 2021

Study Completion Date

May 21, 2021

Conditions

Castration-resistant Prostate CancerMetastasis

Interventions

DRUG

Carboplatin

Tumoral evaluation every 3 cycles

Trial Locations (4)

14076

Centre François Baclesse, Caen

59000

Centre Oscar Lambret, Lille

76000

Chu Rouen, Rouen

Unknown

Institut Gustave ROUSSy IGR, Villejuif

All Listed Sponsors

collaborator

French Interregional Group of Clinical Research and Innovation

OTHER

collaborator

Ligue Contre le Cancer (French association Against Cancer)

UNKNOWN

lead

Centre Francois Baclesse

OTHER

NCT03652493 - Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway | Biotech Hunter | Biotech Hunter